[1]
R. Abooshahab, H. Al-Salami, and C. R. Dass, “Targeting metabolic vulnerabilities in breast cancer cells by combining PEDF and doxorubicin: pathway insights from GC/MS-based metabolomics”, EXCLI J., vol. 24, pp. 1037–1055, Aug. 2025.